Yi Li

机构：First Affiliated Hospital of Sichuan Medical University, CTI BioPharma (Italy) · ORCID：0009-0001-3681-2305

发表论文 108 篇 · 总被引 731 次 · h-index 17

代表论文

• Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for Staging and Restaging of Gastric Cancer (2022 · Frontiers in Oncology · 被引 42)
• Ferroptosis in age-related vascular diseases: Molecular mechanisms and innovative therapeutic strategies (2024 · Biomedicine & Pharmacotherapy · 被引 11)
• S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 10)
• Research on doctor‐patient communication teaching for oncology residents: a new teaching model (2024 · Journal of Evaluation in Clinical Practice · 被引 7)
• Metastatic pulmonary calcification on bone scintigraphy of a patient with lupus nephritis and end-stage renal disease (2023 · Radiology Case Reports · 被引 3)
• Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patients (2025 · International Journal of Cardiology · 被引 2)